| Net Cash Provided by (Used in) Operating Activities |
29.6M |
USD |
+40.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-27.3M |
USD |
+49% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
11.6M |
USD |
-45.2% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
110M |
shares |
+83.3% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
47.3M |
shares |
+5.11% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
13.9M |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
17.9M |
USD |
-48.8% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
7.81M |
USD |
-20.1% |
Q1 2025 |
Q1 2025 |
| Operating Lease, Liability |
2.66M |
USD |
|
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
31.7M |
USD |
-67.1% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.15B |
USD |
+7.92% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
9.16M |
USD |
+0.74% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
332K |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
47.5M |
USD |
+35.9% |
Q1 2024 |
Q1 2024 |